Literature DB >> 16695653

THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.

W S Tillett1, S Sherry.   

Abstract

Entities:  

Year:  1949        PMID： 16695653      PMCID： PMC439589          DOI： 10.1172/JCI102046

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  METHODS FOR MEASURING THE ACTIVITY OF COMPONENTS OF THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM, AND STREPTOCOCCAL DESOXYRIBONUCLEASE.

Authors:  L R Christensen
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

2.  THE OCCURRENCE OF ANTIFIBRINOLYTIC PROPERTIES IN THE BLOOD OF PATIENTS WITH ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.

Authors:  W S Tillett
Journal:  J Clin Invest       Date:  1935-03       Impact factor: 14.808

3.  FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.

Authors:  W S Tillett; L B Edwards; R L Garner
Journal:  J Clin Invest       Date:  1934-01       Impact factor: 14.808

4.  STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. I. THE DISSIMILARITY OF SERUM PROTEASE AND TRYPSIN AS INDICATED BY THE SEPARATE SPECIFICITIES OF THEIR KINASES, FIBRINOLYSIN AND ENTEROKINASE.

Authors:  M H Kaplan
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808
  4 in total
  66 in total

1.  BTS guidelines for the management of pleural infection.

Authors:  C W H Davies; F V Gleeson; R J O Davies
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

3.  THE USE OF FIBRINOLYTIC ACTIVATORS IN MENINGITIS AND SIMILAR CONDITIONS.

Authors:  R L NEWMAN; G T STEWART
Journal:  Arch Dis Child       Date:  1965-06       Impact factor: 3.791

4.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

5.  The response of rheumatic and non-rheumatic children to streptolysin O concentrate.

Authors:  R W QUINN
Journal:  J Clin Invest       Date:  1957-06       Impact factor: 14.808

6.  The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients.

Authors:  W S TILLETT; A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

7.  The intravenous injection of bovine crystalline pancreatic desoxyribonuclease into patients.

Authors:  A J JOHNSON; P R GOGER; W S TILLETT
Journal:  J Clin Invest       Date:  1954-12       Impact factor: 14.808

8.  The enzymatic dissolution of experimental arterial thrombi in the dog by trypsin, chymotrypsin and plasminogen activators.

Authors:  S SHERRY; A TITCHENER; L GOTTESMAN; P WASSERMAN; W TROLL
Journal:  J Clin Invest       Date:  1954-10       Impact factor: 14.808

9.  The fibrinolytic activity of streptokinase activated human plasmin.

Authors:  S SHERRY
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

10.  Intrapleural streptokinase treatment in children with empyema.

Authors:  Metin Aydoğan; Ayşen Aydoğan; Ayla Ozcan; Melih Tugay; Ayse Sevim Gokalp; Emin Sami Arisoy
Journal:  Eur J Pediatr       Date:  2007-08-21       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.